Venkatraman Radhakrishnan
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Venkatraman Radhakrishnan
May 27, 2024, 05:50 |
Blog
Amol Akhade: A Talk about critical analysis of oncology trials in cancer Institute Adyar
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X: “Gave A…
Apr 14, 2024, 07:05 |
Blog
Venkatraman Radhakrishnan: Vacancy for Director of Research, Cancer Institute (W.I.A), Chennai India
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute,…
Jan 24, 2024, 17:18 |
Blog
Venkatraman Radhakrishnan: Time to move away from Dexamethasone for prevention of chemotherapy induced nausea and vomiting
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute,…
Jan 4, 2024, 23:40 |
Opinion
Venkatraman Radhakrishnan: CTRT in locally advanced inoperable breast cancer
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute,…
Nov 3, 2023, 12:01 |
Societies
The Hans-Peter Wagner Prize recognises work in less-resourced settings - World SIOP
World SIOP announced on their X/Twitter page: "The Hans-Peter Wagner Prize recognizes work in less-resourced…
Oct 17, 2023, 01:36 |
Blog
30 Tweets Not To Miss From SIOP 2023 Congress
The 55th Annual Congress of the International Society of Paediatric Oncology (SIOP) took place from…
Oct 15, 2023, 18:30 |
Blog
Suzanne Turner: Our very own SIOP 2023 Ambassador Venkatraman Radhakrishnan awarded the first Hans Peter Wagner prize for his impressive work.
Suzanne Turner, Professor of Childhood Cancer Biology at the University of Cambridge, posted on her…
Oct 13, 2023, 17:15 |
Drugs
Venkatraman Radhakrishnan: Inotuzumab take home points at SIOP 2023.
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute,…
Oct 7, 2023, 17:20 |
Blog
15 posts from ASTRO23 not to miss.
The 65th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2023) took place at…
Sep 26, 2023, 19:20 |
Insight
Venkatraman Radhakrishnan: Reduction in chemo dose intensity by 25% and adding Rituximab improves survival in pediatric high-grade B Non-Hodgkins Lymphoma in resource-limited settings.
Jun 7, 2023, 10:14 |
Opinion
How much does it cost to attend ASCO from a resource limited setting - Venky (Venkatraman Radhakrishnan)
How much does it cost to attend ASCO from a resource limited settings. Let's take…
Jun 7, 2023, 10:11 |
Drugs
Access to medicine should also look at these - Venky (Venkatraman Radhakrishnan)
When delivering chemotherapy the cost of daycare bed, syringes, gloves, needles, IV sets, cannula, pre…
All:
12
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube